01 — At a Glance
The Fragrance Business That’s Anything But Fragrant in Valuation
- 52-Week High / Low₹3,440 / ₹1,398
- Q3 FY26 Revenue₹605 Cr
- Q3 FY26 PAT₹78 Cr
- Q3 EPS (₹)₹19.95
- Annualised EPS (Q3×4)₹79.8
- Book Value₹317
- Price to Book8.98x
- Dividend Yield0.17%
- Debt / Equity0.86x
- 9M FY26 Revenue Growth+24%
The Setup: Privi reported ₹605 crore revenue in Q3 (December 2025), up 23.2% YoY, with PAT growth of 75.5%. Nine-month revenue hit ₹1,857 crore with 24% YoY growth. EBITDA margins expanded to nearly 26% despite what management calls a “subdued market.” The stock is trading at 37x P/E on TTM basis—not cheap by Indian chemical standards, but suddenly interesting if you believe the 5,000 crore revenue roadmap is real. The company is also doing something unusual: its joint venture partner, Givaudan (the Swiss fragrance giant), just handed it ₹150 crore as an interest-free advance. That’s not charity. That’s confidence. Drop a comment if you own any aroma stocks.
02 — Introduction
The Most Boring Sexy Stock in Indian Chemicals
Privi Speciality Chemicals makes something nobody thinks about until their soap smells like roses instead of sadness. Aroma chemicals. Fragrance ingredients. The stuff that goes into your shampoo, your cologne, your perfume, your detergent. Sitting between base raw materials and the final consumer brands you actually know, like a invisible middleman earning fat margins.
The company has been doing this since 1985 with a quiet competence that would make auditors blush. >20% global market share in ten products. India’s largest aroma chemicals manufacturer. 70+ products across four chemical categories. A joint venture with Givaudan (a Swiss company that literally IS global fragrance). 48,000 MTPA capacity that’s about to explode to 54,000+ MTPA. And a board that talks about ₹5,000 crore revenue in 3-4 years like it’s casual conversation, not an BHAG.
What makes this interesting right now is that almost nobody is paying attention. The P/E is 37x, which is expensive on a backwards basis, but cheap if you trust the growth roadmap. The stock is up 91% in one year. And yet, three senior exits in one quarter (MD, CFO, new VP Marketing in Feb 2026) feel like the type of news that should be scary—except management is hiring, promoting, and marching ahead like these are just normal transitions in a growing company.
This is not a distressed name. This is a company compounding in front of the market’s blind spot. Let’s break it down—with the sarcasm, the data, and the commentary that would cost you ₹2 lakh annually at a proper research shop.
Concall Insight (Feb 2026): “We enjoy 18% duty advantage in some markets, and in some cases, it is even 0. We are on track with the 5k:1k plan.” Management also framed their entire narrative around “China+1” supply chain diversification, positioning Privi as a compliant manufacturing hub for global brands. This is macro-tailwind, and everyone’s still treating this stock like a micro-cap.
03 — Business Model: WTF Do They Even Make?
They Turn Turpentine Into Billions. Literally.
Privi starts with crude sulphate turpentine (CST) and gum turpentine oil—the leftover resin from pulp manufacturing. It then uses chemistry, heat, and decades of process know-how to convert these into pinene, citral, phenol, musk, and 60+ other specialty aroma chemicals that end up in your Dove soap or Dior perfume.
The business model has three economic moats: (1) Backward integration—they manufacture key inputs (pinene from turpentine) in-house, insulating them from commodity price swings. (2) Customer contracts—70% of capacity is locked into yearly contracts with global Givaudan, Firmenich, Symrise, P&G, Henkel. (3) Market position—>20% global share in ten products means pricing power and supply reliability that customers depend on.
Revenue split: 70% exports (North America 13%, Europe 18%, Asia excl. India 34%, Rest 28%), 30% India domestic. Product mix: Pinene 34%, Value-Added Products 35%, Musk & Speciality 18%, Citral 13%, Phenol 7%. They also have a JV with Givaudan (51% Privi, 49% Givaudan) manufacturing 40+ exclusive products at a greenfield facility in Mahad. The JV just hit EBITDA positive in Q3 FY26 and expects net profit next year. That’s not background noise. That’s significant.
Global Share>20%In 10 Products
Capacity (MTPA)48,000Expanding to 54k+
Export Mix70%Global Diversified
Facilities7Mahad + Jhagadia
The Backward Integration Play: Pinene is the kingpin. Privi manufactures it from turpentine oil—a by-product others ignore. Because of this, they can offer customers integrated supply and process optimization that competitors can’t match. That’s why management talks about it like it’s their moat. Because it is.
💬 Did you know your perfume’s base chemical probably came from the pulp mill that makes your paper? Drop a comment if you work in fragrance or chemical supply.
04 — Financials Overview
Q3 FY26: The Numbers (Quarterly Results)
Continue reading with a premium membership.
